LFTD Partners Inc. Reports Q3 2025 Basic EPS of $0.04
LFTD Partners (OTCQB: LIFD) reported Q3 2025 results for the quarter ended Sept 30, 2025. Revenue rose 4% to $9,056,742. The company returned to profitability with operating income $1,312,791, net income $634,257, and basic EPS $0.04. Cash on hand fell 7% to $2,920,664 (including $1,000,000 restricted), while inventory rose 8% to $10,077,375 and working capital decreased 10% to $9,764,165. Total goodwill at Sept 30, 2025 was $23,092,794.
The company disclosed that federal legislation signed Nov 12, 2025 bans intoxicating hemp-derived consumables effective Nov 12, 2026 and said that ban could eliminate approximately 47% of Lifted’s sales and likely trigger significant impairment and inventory write-offs.
LFTD Partners (OTCQB: LIFD) ha riportato i risultati del terzo trimestre 2025 per il periodo concluso il 30 settembre 2025. Ricavi sono aumentati del 4% a $9,056,742. L'azienda è tornata in utile con utile operativo $1,312,791, utile netto $634,257 e EPS base $0,04. La liquidità in cassa è scesa del 7% a $2,920,664 (inclusi $1,000,000 restritti), mentre inventario è cresciuto dell'8% a $10,077,375 e capitale circolante è diminuito del 10% a $9,764,165. Il goodwill totale al 30 settembre 2025 era $23,092,794.
La società ha comunicato che la legge federale firmata il 12 novembre 2025 vieta i consumabili derivati dalla canapa intoxicanti a decorrere dal 12 novembre 2026 e ha affermato che tale divieto potrebbe eliminare circa il 47% delle vendite di Lifted e probabilmente comportare un sostanziale impairment e svalutazioni dell'inventario.
LFTD Partners (OTCQB: LIFD) informó los resultados del tercer trimestre de 2025 para el periodo terminado el 30 de septiembre de 2025. Los ingresos subieron un 4% a $9,056,742. La empresa volvió a la rentabilidad con ingreso operativo $1,312,791, ingreso neto $634,257 y EPS básico $0.04. La liquidez en caja cayó un 7% a $2,920,664 (incluyendo $1,000,000 restringidos), mientras que el inventario aumentó un 8% a $10,077,375 y el capital de trabajo disminuyó un 10% a $9,764,165. El fondo de comercio total al 30 de septiembre de 2025 era $23,092,794.
La empresa dio a conocer que la legislación federal firmada el 12 de noviembre de 2025 prohíbe los consumibles intoxicantes derivados del cáñamo a partir del 12 de noviembre de 2026 y dijo que esa prohibición podría eliminar aproximadamente el 47% de las ventas de Lifted y probablemente activar depreciaciones e pérdidas de inventario sustanciales.
LFTD Partners (OTCQB: LIFD) 2025년 3분기 9월 30일 종료 분기의 실적을 발표했습니다. 매출은 4% 증가하여 $9,056,742에 달했습니다. 회사는 영업이익 $1,312,791, 순이익 $634,257, 및 기초 주당순이익 $0.04로 흑자 전환에 성공했습니다. 현금 및 현금성 자산은 7% 감소하여 $2,920,664 (제한된 $1,000,000 포함) 이 되었고, 재고자산은 8% 증가하여 $10,077,375, 운전자본은 10% 감소하여 $9,764,165 이었습니다. 2025년 9월 30일 기준 총 영업권은 $23,092,794였습니다.
회사는 2025년 11월 12일 서명된 연방 법률이 2026년 11월 12일부터 발효되어 마약성 카나비스 유래 소비재를 금지한다고 밝혔으며, 이 금지가 Lifted의 매출의 약 47%를 제거하고 중대한 손상 및 재고 평가손실을 촉발할 수 있다고 말했습니다.
LFTD Partners (OTCQB: LIFD) a publié les résultats du T3 2025 pour le trimestre clos le 30 septembre 2025. Le chiffre d'affaires a augmenté de 4% pour atteindre $9,056,742. L'entreprise est revenue à la rentabilité avec un résultat opérationnel de $1,312,791, un résultat net de $634,257 et un BPA de base de $0,04. La trésorerie disponible a diminué de 7% pour atteindre $2,920,664 (dont $1,000,000 restreints), tandis que l'inventaire a augmenté de 8% pour atteindre $10,077,375 et que le fonds de roulement a diminué de 10% pour atteindre $9,764,165. Le goodwill total au 30 septembre 2025 s'élevait à $23,092,794.
La société a déclaré qu'une législation fédérale signée le 12 novembre 2025 interdit les consommables intoxicants dérivés du chanvre à partir du 12 novembre 2026 et a indiqué que cette interdiction pourrait éliminer environ 47% des ventes de Lifted et probablement entraîner des dépréciations importantes et des liquidations d'inventaire.
LFTD Partners (OTCQB: LIFD) berichtete die Ergebnisse für das Q3 2025 für das Quartal zum 30. September 2025. Umsatz stieg um 4% auf $9,056,742. Das Unternehmen kehrte mit operativem Ergebnis $1,312,791, Nettogewinn $634,257 und grundlegendem EPS $0,04 in die Gewinnzone zurück. Bargeld blieb unverändert? Nein: Liquidität fiel um 7% auf $2,920,664 (einschließlich $1,000,000 eingeschränkt). Inventar stieg um 8% auf $10,077,375 und Working Capital sank um 10% auf $9,764,165. Der gesamte Goodwill per 30. Sept 2025 betrug $23,092,794.
Das Unternehmen gab bekannt, dass die am 12. November 2025 unterzeichnete bundesstaatliche Gesetzgebung ab dem 12. November 2026 intoxicierende, aus Hanf gewonnene Konsumgüter verbietet und sagte, dieses Verbot könnte ungefähr 47% von Lifteds Umsatz eliminieren und wahrscheinlich erhebliche Wertminderungen und Inventurabschreibungen auslösen.
LFTD Partners (OTCQB: LIFD) أبلغت عن نتائج الربع الثالث من 2025 للربع المنتهي في 30 سبتمبر 2025. الإيرادات ارتفعت بنسبة 4% إلى $9,056,742. عادت الشركة إلى الربحية مع دخل تشغيلي $1,312,791، دخل صافي $634,257، و ربح السهم الأساسي $0.04. النقد المتاح تراجع بنسبة 7% إلى $2,920,664 (بما في ذلك $1,000,000 مقيد)، بينما المخزون ارتفع 8% إلى $10,077,375 و رأس المال العامل انخفض 10% إلى $9,764,165. إجمالي goodwill حتى 30 سبتمبر 2025 كان $23,092,794.
أفادت الشركة أن التشريعات الفدرالية الموقعة في 12 نوفمبر 2025 تحظر المستهلكات المستخلصة من القنب المخدِّرة اعتباراً من 12 نوفمبر 2026 وقالت إن هذا الحظر قد يقضي على نحو 47% من مبيعات Lifted وربما يسبب شطباً كبيراً في قيمة الأصول والمخزون.
- Revenue +4% to $9,056,742
- Operating income $1,312,791 (vs operating loss prior year)
- Net income $634,257; Basic EPS $0.04
- Federal ban effective Nov 12, 2026 could eliminate ~47% of sales
- Total goodwill $23,092,794 — potential impairment >50%
- Inventory +8% to $10,077,375 and risk of full write-offs if ban enforced
- Cash down 7% to $2,920,664; working capital down 10% to $9,764,165
JACKSONVILLE, FL., Nov. 17, 2025 (GLOBE NEWSWIRE) -- LFTD Partners Inc. ("LFTD Partners" or the "Company") (OTCQB: LIFD), the corporate parent of leading hemp, wellness and energy products maker Lifted Made (“Lifted”), today reported its financial results for the third quarter ended September 30, 2025. Financial results are reported in accordance with U.S. generally accepted accounting principles and all currency is in U.S. dollars.
Income Statement – Q3 2025 Compared to Q3 2024:
- Revenue increased
4% to$9,056,742 , up from$8,691,675 - Operating income was
$1,312,791 , up from an operating loss of$140,703 - Net income was
$634,257 , up from a net loss of$194,399 - Basic net income per share was
$0.04 per share, up from a loss of$0.01 per share - Diluted net income per share was
$0.04 per share, up from a loss of$0.01 per share - Basic weighted average number of common shares outstanding for the three months ended September 30, 2025 was 14,822,678
- Diluted weighted average number of common shares outstanding for the three months ended September 30, 2025 was 14,964,678
Balance Sheet – September 30, 2025 Compared to December 31, 2024:
- Cash on hand, which includes
$1,000,000 of restricted cash, decreased7% to$2,920,664 , down from$3,146,947 - Inventory increased
8% to$10,077,375 , up from$9,316,291 - Current assets decreased
14% to$14,591,256 , down from$16,928,005 - Current ratio increased to 3.02 from 2.78
- Working capital decreased
10% to$9,764,165 , down from$10,843,994 - Notes payable to Surety Bank decreased
30% to$2,336,259 , down from$3,348,790
Federal Legislation
On November 12, 2025, President Trump signed into law H.R. 5371, the “Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026” (the “Act”), which makes continuing appropriations and extensions for fiscal year 2026, and which also bans intoxicating hemp-derived consumable products nationally on November 12, 2026. It is unknown to the Company whether or not the sections of the Act that impact the hemp industry will ultimately go into effect on November 12, 2026, or if those sections will be replaced, impacted or amended by subsequent acts of Congress. However, the Act in all likelihood will have a devastating impact on the Company and the price of its common stock. The material adverse effects of the Act cannot be overstated; these material adverse effects include, but are not limited to, the following:
| 1 | ) | The elimination of half or more of Lifted’s sales. Sales of hemp-derived products made up approximately | |
| 2 | ) | Goodwill impairment charges. As a result of LFTD Partners' acquisition of Lifted, LFTD Partners recognized goodwill of | |
| 3 | ) | An investment impairment charge. The Act will necessitate the calculation and recording of an impairment of LFTD Partners’ investment in hemp-derived beverage and products maker Ablis. LFTD Partners’ investment in Ablis was reported as | |
| 4 | ) | Significant inventory write offs. The Act will most likely negatively impact the pricing of hemp-derived products, the availability and price of raw goods and production forecasting, which will lead to increased write-offs each quarter end. Moreover, any hemp-derived products in inventory on November 12, 2026 will have to be written off. |
About LFTD Partners Inc.
Publicly traded LFTD Partners Inc., Jacksonville, FL (OTCQB: LIFD) is the parent corporation of leading hemp, wellness and energy products maker Lifted Made, Kenosha, WI, which manufactures and sells hemp-derived and other psychoactive products under its award-winning Urb brand and other brands, hemp-free health and wellness gummies under its Mielos brand, and hemp-free energy gummies under its Rebel brand. LFTD Partners Inc. also owns
Cautionary Note Regarding Forward-Looking Statements
Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such information includes the operations, financing, growth, performance, products, plans and expectations of LFTD Partners Inc. and Lifted Liquids, Inc. d/b/a Lifted Made and d/b/a Urb Finest Flowers. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to these companies' actual operations, financing, growth, performance, products, plans or results of these companies differing materially from those expressed or implied by the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain other factors, including the risk factors set forth in LFTD Partners Inc.'s filings with the Securities and Exchange Commission. None of the statements contained herein have been approved by the Food and Drug Administration, and none of the products manufactured or sold by Lifted Made are intended to diagnose, treat, cure or prevent any disease. This press release does not constitute an offer to sell common stock or any other securities of LFTD Partners Inc.
Contact Information
Gerard M. Jacobs
Chairman and CEO of LFTD Partners Inc.
(847) 915-2446
GerardMJacobs@LFTDPartners.com
Nicholas S. Warrender
Vice Chairman and COO of LFTD Partners Inc.
(224) 577-8148
CEO@urb.shop
William C. "Jake" Jacobs
President and CFO of LFTD Partners Inc.
(847) 400-7660
JakeJacobs@LFTDPartners.com
SOURCE: LFTD Partners Inc.
FAQ
What were LFTD Partners (LIFD) Q3 2025 revenue and EPS?
How did LFTD Partners’ profitability change in Q3 2025 compared to Q3 2024?
What cash and inventory levels did LIFD report at Sept 30, 2025?
What impact could the Nov 12, 2026 federal ban have on LFTD Partners (LIFD)?
How large is LFTD Partners’ goodwill that may be impaired?
When did LFTD Partners disclose the federal legislation risk and which law was cited?
